Biotech Stock News (VRX) (ONTX) (BXLT) (SHPG)

Valeant Pharmaceuticals (NYSE:VRX) On Monday March 4, 2016 Valeant Pharmaceuticals fell down 7% in the morning as the company announced that it will have to delay its financial results. This left investors jittery and in panic mode, because they had and still have no clue why earnings are being pushed back so much. One possible … Read more

Biotech Stock News (BLUE) (SNTA) (MACK) (BXLT)

Bluebird Bio (NASDAQ:BLUE)  On October 19, 2015 shares of Bluebird Bio fell approximately 4% after the company announced that one patient on its old generation gene therapy had required two blood transfusions due to anemia. One thing to keep in mind was that this patient was blood transfusion free for 7 years and that’s why … Read more

Biotech Stock News: (GALE) (AMGN) (ARIA) (BXLT)

Galena Biopharma (NASDAQ:GALE) On Monday August 24, 2015 Shares of Galena Biopharma were able to close the day up 11% after announcing an update for its phase 3 trial known as the “PRESENT” trial. The company announced that the independent data monitoring committee — IDMC — concluded that it would be able to reduce the … Read more

Undervalued Baxalta Shares Target of Acquisition by Shire Plc

Baxalta (BXLT) was recently spun-off from Baxter International (BAX) on July 1st, 2015. The company has 16,000 employees and around $6 billion in expected revenues. Baxalta is expected to have around $2.15 in earnings-per-share in its first full fiscal year. The company has traded around $32 a share since the spin-off. This translates to a … Read more

Baxalta: A Rare Undervalued Biopharmaceutical Company

Baxalta (BXLT) was created on July 1st 2015 when Baxter (BAX) spun-off its biopharmaceutical division. Baxalta may be new, but it is no start-up company.  Baxalta has estimated annual revenues of around $6 billion, and 16,000 employees. Around 50% of Baxalta’s sales come from the United States, with the other 50% from international markets. The … Read more